Examkin

Question

Difficulty: MediumDepressive Disorders

A 54-year-old software developer with no prior psychiatric history is evaluated for Major Depressive Disorder (MDD). Arrange the following pharmacological and somatic management steps in the correct chronological sequence according to standard stepped-care escalation protocols, starting from the initial presentation to the eventual management of a severe, life-threatening refractory state.

  1. 1Initiate monotherapy with a selective serotonin reuptake inhibitor (SSRI).
  2. 2Switch to a different antidepressant class (e.g., an SNRI) after an adequate trial yields zero clinical improvement.
  3. 3Augment the current regimen with an atypical antipsychotic following a partial response to the second antidepressant.
  4. 4Administer electroconvulsive therapy (ECT) upon the development of treatment-resistant depression complicated by acute food refusal.

Answer

The correct sequence of treatment escalation for MDD is: 1) Initiate SSRI monotherapy, 2) Switch to an SNRI for non-response, 3) Augment with an atypical antipsychotic for partial response, and 4) Administer ECT for life-threatening treatment-resistant depression.
The correct stepped-care escalation for major depressive disorder begins with SSRI monotherapy. If there is no response, switching to a different antidepressant (like an SNRI) is indicated. If there is a subsequent partial response, augmentation (e.g., with an atypical antipsychotic) is preferred to maximize the partial gains. Finally, if the patient becomes completely treatment-resistant and develops life-threatening complications like food refusal, ECT is the definitive, rapid-acting treatment of choice.

Step-by-Step Solution

1
Identify the appropriate first-line treatment for an initial MDD diagnosis.
Initiation of an SSRI.
SSRIs have a favorable side-effect profile and are the universally recommended starting point for uncomplicated MDD.
2
Determine the best management strategy for a patient who shows absolutely no response to the first-line agent after an adequate trial.
Switch to an alternative monotherapy (e.g., an SNRI).
Switching minimizes polypharmacy and is preferred when the initial drug provides zero benefit.
3
Determine the next step if the second agent provides only partial symptom relief.
Augmentation with an adjunctive agent like an atypical antipsychotic.
Augmentation builds upon the partial response already achieved without having to cross-taper and risk losing those partial gains.
4
Identify the definitive treatment for refractory depression that has become acutely life-threatening.
Electroconvulsive therapy (ECT).
ECT provides rapid, definitive treatment for severe depression complicated by immediate physical risks such as starvation from food refusal.

Key Concept

The stepped-care approach to Major Depressive Disorder involves initiating first-line monotherapy, switching agents for complete non-response, augmenting for partial response, and utilizing somatic therapies like ECT for severe, treatment-resistant, or life-threatening disease.
Rate this question

Topics

Depressive Disorders

More questions from this topic